Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Whitney Elizabeth Goode, D.M.D.

Concepts (14)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Whitney Goode's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Whitney Goode has written about over time.
Animals, 1 publications between 2004 and 2004, average publication date April 2004. Apoptosis, 1 publications between 2004 and 2004, average publication date April 2004. Cell Line, 1 publications between 2004 and 2004, average publication date April 2004. Cell Survival, 1 publications between 2004 and 2004, average publication date April 2004. Dose-Response Relationship, Drug, 1 publications between 2004 and 2004, average publication date April 2004. Enzyme Inhibitors, 1 publications between 2004 and 2004, average publication date April 2004. Mice, 1 publications between 2004 and 2004, average publication date April 2004. Microglia, 1 publications between 2004 and 2004, average publication date April 2004. Nitric Oxide, 1 publications between 2004 and 2004, average publication date April 2004. Nitric Oxide Synthase, 1 publications between 2004 and 2004, average publication date April 2004. Nitric Oxide Synthase Type I, 1 publications between 2004 and 2004, average publication date April 2004. Pyrazines, 1 publications between 2004 and 2004, average publication date April 2004. Thiones, 1 publications between 2004 and 2004, average publication date April 2004. Thiophenes, 1 publications between 2004 and 2004, average publication date April 2004.

To see the data from this visualization as text, click here.
Goode's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (14)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.